thyroxine has been researched along with Hypophysitis in 2 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Hypophysitis: Inflammation of the PITUITARY GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the incidence, diagnosis and treatment of immune-related adverse events (e-irAE) of checkpoint inhibition (ICI) in metastatic urothelial carcinoma (mUC) and metastatic renal cell carcinoma (mRCC)." | 1.91 | Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors. ( Burger, M; Büttner, R; Oppolzer, IA; Riester, J; Schnabel, MJ, 2023) |
| "Hypophysitis is one of the most common endocrine abnormalities." | 1.62 | Predicting development of ipilimumab-induced hypophysitis: utility of T4 and TSH index but not TSH. ( Greener, V; Lai, ZM; Larkin, J; Morganstein, DL; Siddiqui, MS; Spain, L; Turajlic, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oppolzer, IA | 1 |
| Riester, J | 1 |
| Büttner, R | 1 |
| Burger, M | 1 |
| Schnabel, MJ | 1 |
| Siddiqui, MS | 1 |
| Lai, ZM | 1 |
| Spain, L | 1 |
| Greener, V | 1 |
| Turajlic, S | 1 |
| Larkin, J | 1 |
| Morganstein, DL | 1 |
2 other studies available for thyroxine and Hypophysitis
| Article | Year |
|---|---|
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors.
Topics: Antineoplastic Agents, Immunological; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Humans; H | 2023 |
Predicting development of ipilimumab-induced hypophysitis: utility of T4 and TSH index but not TSH.
Topics: Adult; Aged; Antineoplastic Agents, Immunological; Biomarkers; Female; Follow-Up Studies; Humans; Hy | 2021 |